Alembic Pharmaceuticals Ltd Financials Statements

    Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

    Consolidate
    Standalone
    Financial Year
    Mar '25
    Dec '24
    Sep '24
    Jun '24
    Mar '24
    Total Qtr Revenue cr
    1,783.83
    1,702.24
    1,664.72
    1,563.83
    1,520.58
    Other Income Qtr Cr14.199.5016.742.103.60
    Operating Revenues Qtr1,769.641,692.741,647.981,561.731,516.98

    *All values are in Cr.

    Operating Expenses Qtr
    1,497.71
    1,432.52
    1,408.71
    1,324.90
    1,256.92
    Operating Profit Qtr
    271.93
    260.22
    239.27
    236.83
    260.06
    EBITDA Qtr Cr
    286.12
    269.72
    268.88
    238.93
    263.66
    Depreciation Qtr
    68.99
    70.04
    70.51
    69.04
    69.48
    Net Profit Qtr
    156.89
    138.42
    153.40
    134.71
    178.21
    Basic EPS Qtr
    7.98
    7.01
    7.79
    6.85
    9.07
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -